Clinical Trial Update: The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) [Phase 2]

View source ↗

Summary

Phase 2 trial update for The TRIDENT Study evaluating transendocardial stem cell injection delivery effects on neomyogenesis in chronic ischemic left ventricula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Left Ventricular Dysfunction
• Myocardial Infarction

Snippet

Sponsor: Joshua M Hare | Conditions: Chronic Ischemic Left Ventricular Dysfunction, Myocardial Infarction | Phase 2 | Status: COMPLETED | Results posted: 2020-02-05